These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 5660824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Hormonal therapy of metastizing breast cancer].
    von Werder K.
    Med Klin; 1976 Feb 20; 71(8):313-21. PubMed ID: 56699
    [No Abstract] [Full Text] [Related]

  • 3. [Hormonal prevention of recurrence and metastasis in the complex treatment of breast cancer].
    Vishniakova EG.
    Vopr Onkol; 1968 Feb 20; 14(3):74-9. PubMed ID: 4968229
    [No Abstract] [Full Text] [Related]

  • 4. [Endocrine therapy and chemotherapy of breast cancer].
    Watabe H, Abe H, Ogata T, Kumaoka S, Sakauchi N.
    Shujutsu; 1969 Aug 20; 23(8):998-1005. PubMed ID: 5358430
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic results of androgen treatment and ovariectomy in breast cancer].
    Schöll A.
    Norm Pathol Anat (Stuttg); 1975 Aug 20; (30):1-46. PubMed ID: 1208202
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Hormone-therapy of carcinoma of the breast].
    Villani C, Mazzon I.
    Minerva Ginecol; 1981 Jan 20; 33(1):3-26. PubMed ID: 7017505
    [No Abstract] [Full Text] [Related]

  • 10. Cancer of the second breast.
    Donegan WL, Spratt JS.
    Major Probl Clin Surg; 1967 Jan 20; 5():179-89. PubMed ID: 5634182
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Current problems in the therapy of diffuse breast carcinoma].
    Di Pietro S.
    Minerva Radiol; 1968 Oct 20; 13(10):569-73. PubMed ID: 5734810
    [No Abstract] [Full Text] [Related]

  • 13. [Hormonal prevention of recurrence of breast carcinoma].
    Ehlers PN.
    Wien Klin Wochenschr; 1970 Jun 26; 82(26):478-81. PubMed ID: 5520163
    [No Abstract] [Full Text] [Related]

  • 14. [Endocrine therapy of female breast carcinoma dependent upon the number of Barr bodies].
    Klug W.
    Chirurg; 1969 Jan 26; 40(1):33-6. PubMed ID: 5350842
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The importance of sex chromatin determination in the hormonal treatment of breast cancer.
    Siracká E, Simko I, Siracký J.
    Neoplasma; 1970 Jan 26; 17(6):625-9. PubMed ID: 5505379
    [No Abstract] [Full Text] [Related]

  • 17. [Endocrine-surgical treatment of skeletal metastases].
    Dagradi A, Petronio R.
    Clin Ortop; 1972 Jan 26; 23(1):1-25. PubMed ID: 5084890
    [No Abstract] [Full Text] [Related]

  • 18. [Data on the so-called "aimed hormone therapy" of breast cancer].
    Vághy IM, Ladányi J, Matolay G.
    Orv Hetil; 1968 Jan 21; 109(3):130-2. PubMed ID: 5675681
    [No Abstract] [Full Text] [Related]

  • 19. Certain aspects of the medical management of metastatic breast cancer.
    Abeloff MD.
    Johns Hopkins Med J; 1974 Feb 21; 134(2):84-9. PubMed ID: 4811013
    [No Abstract] [Full Text] [Related]

  • 20. The management of advanced breast cancer.
    Hunt PS, Nemoto T.
    Med J Aust; 1970 Sep 26; 2(13):591-4. PubMed ID: 5471114
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.